2003

Jul 18, 2003
Guidant Urges Conferees to Move Swiftly on Medicare Reform

Calls on Conference to Seize Historic Opportunity to Improve Quality and Expand Access Through Greater Choice, Competition and Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a...

Jul 17, 2003
Guidant Announces U.S. Approval of Newest Implantable Defibrillator for the Treatment of Irregular Heart Rhythms

World''s Smallest Dual Chamber System Offers Enhanced Therapies to Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...

Jul 17, 2003
Guidant Reports Record Sales of $945 Million in Second Quarter, Growth of 20 Percent

Worldwide implantable cardioverter defibrillator revenues of $377 million, up 50 percent; Worldwide stent revenue of $224 million, down 2 percent; Favorable product mix generates 75.4 percent...

Jul 16, 2003
Guidant Receives U.S. Approval for First Cobalt Chromium Coronary Stent System

Next-Generation Stent Design and Excellent Clinical Results Offer Expanded Treatment Options for Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Jul 14, 2003
New Study Shows Excellent Six-Month Results for Guidant's Market-Leading Small Vessel Stent

European Trial Demonstrates Low Restenosis Rate in Stenting of Small Vessels Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...

Show 5102550100 per page
Top